stockrowMaravai LifeSciences Holdings, Inc.
MRVI Healthcare Biotechnology
Maravai LifeSciences Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $185.7 million, down 28.3% from fiscal 2024.
- Revenue
- +10.1%
- EPS
- +50.0%
- Free cash flow
- +123.9%
- Total debt
- −45.4%
Quarter to September 2026, against a year earlier
Follow MRVI
Alert me
Maravai LifeSciences Holdings, Inc. (MRVI) Operating cash flow
Maravai LifeSciences Holdings, Inc.'s operating cash flow for fiscal 2025 was −$57.6M, compared with $7.5M in fiscal 2024. Over the twelve months to 30 September 2026 it was −$5.1M. Over the past ten years it has ranged from −$57.6M (fiscal 2025) to $536.0M (fiscal 2022) — the current reading is the lowest in ten years. Operating cash flow has fallen for 3 consecutive fiscal years. Maravai LifeSciences Holdings, Inc. ranks 82nd of 603 Biotechnology companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2025 | −$57.6M | — |
| FY2024 | $7.5M | (94.09%) |
| FY2023 | $126.2M | (76.45%) |
| FY2022 | $536.0M | 45.42% |
| FY2021 | $368.6M | 142.18% |
| FY2020 | $152.2M | 531.09% |
| FY2019 | $24.1M | — |
| FY2018 | −$186.0K | — |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $5.0M | 25.63% |
| Jun 2026 | $4.0M | (53.93%) |
| Mar 2026 | $8.7M | — |
| Dec 2025 | −$22.8M | — |
| 25 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| HRMY Harmony Biosciences Holdings, Inc. compare | $323.0M |
| SRPT Sarepta Therapeutics, Inc. compare | $185.6M |
| MRVI Maravai LifeSciences Holdings, Inc. | −$5.1M |
| TRVI Trevi Therapeutics, Inc. compare | −$52.6M |
| MESO Mesoblast Limited compare | −$83.5M |
| MAZE Maze Therapeutics, Inc. compare | −$106.5M |
| TRAX First Tracks Biotherapeutics, Inc. compare | −$112.2M |
| VIR Vir Biotechnology, Inc. compare | −$141.0M |
| REPL Replimune Group, Inc. compare | −$245.5M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item